Gil M. Labrucherie, SVP, COO & CFO at NEKTAR THERAPEUTICS (NKTR), sold 45,298 shares at $13.16 ($595K) on 2021-11-16, disclosed to the SEC on 2021-11-18.
Seasonal sale ($595k) by SVP, COO & CFO — this insider has traded NKTR in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.16 | 21,149 | $278K | 46.8% |
| 2 | $13.16 | 21,149 | $278K | 46.8% |
| 3 | $12.69 | 3,000 | $38K | 6.4% |
| Total | $13.13 avg | 45,298 | $595K | 100% |
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |